Novo Nordisk A/S annual free cash flow for fiscal TTM was DKK 48.9 billion, an increase of 68.7% from DKK 29.0 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | DKK 48.9B | DKK 29.0B | DKK 69.7B | DKK 70.0B | DKK 64.1B | DKK 47.6B | DKK 29.9B | DKK 35.6B | DKK 32.2B | DKK 32.5B | DKK 40.0B | DKK 31.9B | DKK 27.4B | DKK 22.3B | DKK 18.6B | DKK 18.0B | DKK 15.8B | DKK 12.3B | DKK 10.9B | DKK 7.6B | DKK 4.4B |
DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | DKK 42.4B | DKK 12.0B | (DKK 36.2B) | DKK 30.7B | DKK 24.5B | DKK 10.0B | (DKK 4.3B) | DKK 31.3B | DKK 37.3B |
DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NVO metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All NVO financial statements → Interactive NVO charts →
About TickerBase · Data methodology & sources · Privacy · Terms